CSF formation begins with active ion transport by the choroid plexus epithelium, which creates an osmotic gradient across the cell layer. This osmotic gradient draws water into the ventricular space, and water moves readily through Aquaporin-1 channels on the epithelial cells into the CSF. So the sequence is ions moved to generate the osmotic pull, followed by water movement via AQP1. The other ideas don’t fit: water moving first would not establish the driving force, diffusion of water is too slow to account for CSF production, and CSF isn’t produced by vesicular secretion from neurons.

The main concept is that MR perfusion and CT perfusion rely on different types of contrast agents because the imaging physics and how the contrast behaves in tissue differ. For MR perfusion, gadolinium-based contrast agents are used because they affect magnetic relaxation properties, allowing dynamic susceptibility or T1/T2 changes to be tracked as contrast passes through the brain’s microvasculature. For CT perfusion, iodinated contrast agents are used because they change X-ray attenuation, which CT measures as changes in Hounsfield units over time. These agents also differ in how they behave in tissue and with the blood–brain barrier. Gadolinium-based agents can leak from vessels into the interstitial space when the BBB is compromised, which can alter MR signal in ways that complicate perfusion measurements unless leakage is accounted for (for example, with preload strategies or leakage-correction algorithms). Iodinated contrast mainly stays within the intravascular and extracellular space, and while BBB disruption can affect its distribution, the imaging and quantification methods in CT perfusion handle these changes differently. In short, the two modalities use different contrast agents because the underlying physics dictate distinct ways to measure perfusion, and this leads to differences in how BBB integrity and leakage influence the results.

The internal carotid artery, as it enters the brain, ends by giving rise to two major branches that form the anterior circulation: the anterior cerebral artery and the middle cerebral artery. The posterior cerebral artery belongs to the posterior circulation and typically arises from the basilar artery, with a possible connection to the internal carotid via the posterior communicating artery, but it is not a direct terminal branch of the internal carotid. So the two direct terminal branches to remember are the anterior cerebral and middle cerebral arteries, which is why the pairing including the posterior cerebral artery does not reflect the usual direct termination of the internal carotid.

CSF is produced continuously by the choroid plexus at a fairly high rate to maintain normal intracranial dynamics. The production rate is typically around 0.3–0.4 mL per minute, which amounts to roughly 400–600 mL per day. Because individual variation and measurement methods exist, many reference ranges extend toward the higher end, approaching about 700–800 mL per day in some contexts. This is why the gündel answer uses an approximate daily production near 800 mL/day—the upper end of the commonly cited range. The key idea is that CSF turnover is high enough to require a daily production on the order of several hundred milliliters, with 800 mL/day representing a plausible upper-end estimate used in many clinical references.

The barrier tight junctions are created by the capillary endothelial cells that line brain microvessels. These endothelial cells form the actual seal between adjacent vessels, giving the blood-brain barrier its characteristic low paracellular permeability. Astrocyte end-feet support and help regulate the barrier by signaling to endothelial cells and contributing to the surrounding basement membrane, but the tight junctions themselves are formed by the endothelial cells. Oligodendrocyte processes make myelin, not barrier junctions, and meningeal fibroblasts reside in the meninges rather than the brain capillaries.